International Journal of Cancer Management

Published by: Kowsar
Crossmark

Gallic Acid Inhibits Invasion and Reduces IL-6 Gene Expression, pSTAT3, pERK1/2, and pAKT Cellular Signaling Proteins in Human Prostate Cancer DU-145 Cells

Esfandiar Heidarian 1 , * , Mahnaz Keloushadi 2 , Keihan Ghatreh-Samani 3 and Effat Jafari-Dehkordi 4
Authors Information
1 Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
2 Student Research Committee, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
4 Research Institute for Islamic and Complementary Medicine, School of Iranian Traditional Medicine, Iran University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: November 2017, 10 (11); e9163
  • Published Online: November 30, 2017
  • Article Type: Research Article
  • Received: September 26, 2016
  • Revised: November 16, 2016
  • Accepted: October 28, 2017
  • DOI: 10.5812/ijcm.9163

How to Cite: Heidarian E, Keloushadi M, Ghatreh-Samani K, Jafari-Dehkordi E. Gallic Acid Inhibits Invasion and Reduces IL-6 Gene Expression, pSTAT3, pERK1/2, and pAKT Cellular Signaling Proteins in Human Prostate Cancer DU-145 Cells, Int J Cancer Manag. 2017 ; 10(11):e9163. doi: 10.5812/ijcm.9163.

Abstract
Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. American Cancer Society . Cancer facts and figures 2014. Atlanta: American Cancer Society; 2014. Available from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf.
  • 2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. [PubMed: 25651787].
  • 3. Vlachostergios PJ, Papandreou CN. Targeting neuroendocrine prostate cancer: molecular and clinical perspectives. Front Oncol. 2015;5:6. doi: 10.3389/fonc.2015.00006. [PubMed: 25699233].
  • 4. Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: From physiopathology to therapy. J Hepatol. 2016;64(6):1403-15. doi: 10.1016/j.jhep.2016.02.004. [PubMed: 26867490].
  • 5. Nguyen DP, Li J, Tewari AK. Inflammation and prostate cancer: the role of interleukin 6 (IL-6). BJU Int. 2014;113(6):986-92. doi: 10.1111/bju.12452. [PubMed: 24053309].
  • 6. Lonergan PE, Tindall DJ. Androgen receptor signaling in prostate cancer development and progression. J Carcinog. 2011;10:20. doi: 10.4103/1477-3163.83937. [PubMed: 21886458].
  • 7. Heidarian E, Keloushadi M, Ghatreh-Samani K, Valipour P. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells. Biomed Pharmacother. 2016;84:264-9. doi: 10.1016/j.biopha.2016.09.046. [PubMed: 27665471].
  • 8. Culig Z. Proinflammatory cytokine interleukin-6 in prostate carcinogenesis. Am J Clin Exp Urol. 2014;2(3):231-8. [PubMed: 25374925].
  • 9. Eskandari E, Heidarian E, Amini SA, Saffari Chaleshtori J. Evaluating the effects of ellagic acid on pSTAT3, pAKT, and pERK1/2 signaling pathways in prostate cancer PC3 cells. J Cancer Res Ther. 2016;12(4):1266-71. doi: 10.4103/0973-1482.165873. [PubMed: 28169238].
  • 10. Santoni M, Massari F, Del Re M, Ciccarese C, Piva F, Principato G, et al. Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer. Expert Opin Investig Drugs. 2015;24(6):809-24. doi: 10.1517/13543784.2015.1020370. [PubMed: 25746129].
  • 11. Kaur M, Velmurugan B, Rajamanickam S, Agarwal R, Agarwal C. Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm Res. 2009;26(9):2133-40. doi: 10.1007/s11095-009-9926-y. [PubMed: 19543955].
  • 12. Mansouri MT, Farbood Y, Sameri MJ, Sarkaki A, Naghizadeh B, Rafeirad M. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 2013;138(2-3):1028-33. doi: 10.1016/j.foodchem.2012.11.022. [PubMed: 23411210].
  • 13. Huang PJ, Hseu YC, Lee MS, Senthil Kumar KJ, Wu CR, Hsu LS, et al. In vitro and in vivo activity of gallic acid and Toona sinensis leaf extracts against HL-60 human premyelocytic leukemia. Food Chem Toxicol. 2012;50(10):3489-97. doi: 10.1016/j.fct.2012.06.046. [PubMed: 22771367].
  • 14. Lu Y, Jiang F, Jiang H, Wu K, Zheng X, Cai Y, et al. Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur J Pharmacol. 2010;641(2-3):102-7. doi: 10.1016/j.ejphar.2010.05.043. [PubMed: 20553913].
  • 15. Pandurangan AK. Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev. 2013;14(4):2201-5. [PubMed: 23725112].
  • 16. Chun JY, Tummala R, Nadiminty N, Lou W, Liu C, Yang J, et al. Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer. 2010;1(8):868-76. doi: 10.1177/1947601910383416. [PubMed: 21442031].
  • 17. Hwang SL, Yen GC. Effect of hesperetin against oxidative stress via ER- and TrkA-mediated actions in PC12 cells. J Agric Food Chem. 2011;59(10):5779-85. doi: 10.1021/jf104632a. [PubMed: 21486081].
  • 18. Nagakawa O, Ogasawara M, Fujii H, Murakami K, Murata J, Fuse H, et al. Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells. Cancer Lett. 1998;133(1):27-33. [PubMed: 9929157].
  • 19. Yin QH, Yan FX, Zu XY, Wu YH, Wu XP, Liao MC, et al. Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology. 2012;64(1):43-51. doi: 10.1007/s10616-011-9389-y. [PubMed: 21938469].
  • 20. Rezaei A, Heidarian E. Co-administration of trientine and flaxseed oil on oxidative stress, serum lipids and heart structure in diabetic rats. Indian J Exp Biol. 2013;51(8):646-52. [PubMed: 24228388].
  • 21. Heidarian E, Saffari J, Jafari-Dehkordi E. Hepatoprotective action of Echinophora platyloba DC leaves against acute toxicity of acetaminophen in rats. J Diet Suppl. 2014;11(1):53-63. doi: 10.3109/19390211.2013.859217. [PubMed: 24409975].
  • 22. Heidarian E, Jafari Dehkordi E, Seidkhani Nahal A. Lipid lowering effect of artichoke on liver phosphatidate phosphohydrolase and plasma lipids in hyperlipidemic rats. J Med Plant Res. 2011;5(19):4918-24.
  • 23. Heidarian E, Rafieian Kopaei M. Effect of silymarin on liver phoshpatidate phosphohydrolase in hyperlipidemic rats. Biosci Res. 2012;9(2):59-67.
  • 24. Chen HM, Wu YC, Chia YC, Chang FR, Hsu HK, Hsieh YC, et al. Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett. 2009;286(2):161-71. doi: 10.1016/j.canlet.2009.05.040. [PubMed: 19589639].
  • 25. Veluri R, Singh RP, Liu Z, Thompson JA, Agarwal R, Agarwal C. Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells. Carcinogenesis. 2006;27(7):1445-53. doi: 10.1093/carcin/bgi347. [PubMed: 16474170].
  • 26. Paolini A, Curti V, Pasi F, Mazzini G, Nano R, Capelli E. Gallic acid exerts a protective or an anti-proliferative effect on glioma T98G cells via dose-dependent epigenetic regulation mediated by miRNAs. Int J Oncol. 2015;46(4):1491-7. doi: 10.3892/ijo.2015.2864. [PubMed: 25646699].
  • 27. Garcia-Rivera D, Delgado R, Bougarne N, Haegeman G, Berghe WV. Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells. Cancer Lett. 2011;305(1):21-31. doi: 10.1016/j.canlet.2011.02.011. [PubMed: 21420233].
  • 28. Yoon CH, Chung SJ, Lee SW, Park YB, Lee SK, Park MC. Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Joint Bone Spine. 2013;80(3):274-9. doi: 10.1016/j.jbspin.2012.08.010. [PubMed: 23058179].
  • 29. Ho HH, Chang CS, Ho WC, Liao SY, Wu CH, Wang CJ. Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K/AKT/small GTPase signals. Food Chem Toxicol. 2010;48(8-9):2508-16. doi: 10.1016/j.fct.2010.06.024. [PubMed: 20600540].
  • 30. Park WH. MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition. Mol Med Rep. 2011;4(1):193-4. doi: 10.3892/mmr.2010.361. [PubMed: 21461585].
  • 31. Ghosh PM, Malik S, Bedolla R, Kreisberg JI. Akt in prostate cancer: possible role in androgen-independence. Curr Drug Metab. 2003;4(6):487-96. [PubMed: 14683476].
  • 32. Siddiqui WA, Ahad A, Ahsan H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. Arch Toxicol. 2015;89(3):289-317. doi: 10.1007/s00204-014-1448-7. [PubMed: 25618543].
  • 33. Manna PR, Stocco DM. The role of specific mitogen activated protein kinase signaling cascades in the regulation of steroidogenesis. J Signal Transduct. 2011;2011:13. doi: 10.1155/2011/821615.
  • 34. Wang W, Zhao C, Jou D, Lu J, Zhang C, Lin L, et al. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3. Anticancer Res. 2013;33(10):4279-84. [PubMed: 24122993].
  • 35. Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37(9):11553-72. doi: 10.1007/s13277-016-5098-7. [PubMed: 27260630].
  • 36. Wegiel B, Bjartell A, Culig Z, Persson JL. Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer. 2008;122(7):1521-9. doi: 10.1002/ijc.23261. [PubMed: 18027847].
  • 37. Chen L, He HY, Li HM, Zheng J, Heng WJ, You JF, et al. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett. 2004;215(2):239-47. doi: 10.1016/j.canlet.2004.05.023. [PubMed: 15488643].
  • 38. Shen KH, Hung SH, Yin LT, Huang CS, Chao CH, Liu CL, et al. Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. Mol Cell Biochem. 2010;333(1-2):279-91. doi: 10.1007/s11010-009-0229-8. [PubMed: 19693651].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments